Format

Send to

Choose Destination
Ann Surg Oncol. 2011 Oct;18(11):3096-101. doi: 10.1245/s10434-011-1910-1. Epub 2011 Sep 27.

Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution.

Author information

1
Department of Surgery, Division of Surgical Oncology, Mayo Clinic, Phoenix, Arizona, USA.

Abstract

INTRODUCTION:

Radioactive seed localization (RSL) is an alternative to wire localization for nonpalpable breast lesions, with reported lower rates of positive surgical margins.

METHODS:

A retrospective review of all consecutive RSL procedures performed at a single institution from 01/2003 through 10/2010 was conducted.

RESULTS:

One thousand RSL breast procedures were performed in 978 patients. Indications for RSL included invasive carcinoma (52%), in situ carcinoma (22%), atypical hyperplasia (11%), and suspicious percutaneous biopsy findings (15%). A total of 1,148 seeds were deployed using image guidance, with 76% placed ≥1 day before surgery. Most procedures (86%) utilized one seed. A negative margin was achieved at the first operation in 97% of patients with invasive carcinoma and 97% of patients with ductal carcinoma in situ (DCIS). An additional 9% of patients with invasive carcinoma and 19% of patients with DCIS had close (≤2 mm) margins, and underwent re-excision. Sentinel lymph node biopsy was successfully performed in 99.8% of cases. Adverse events included 3 seeds (0.3%) not deployed correctly on first attempt and 30 seeds (2.6%) displaced from the breast specimen during excision of the targeted lesion. All seeds were successfully retrieved, with no radiation safety concerns. Local recurrence rates were 0.9% for invasive breast cancer and 3% for DCIS after mean follow-up of 33 months. There was no evidence of a learning curve.

CONCLUSIONS:

RSL is a safe, effective procedure that is easy to learn, with a low incidence of positive/close margins. RSL should be considered as the method of choice for localization of nonpalpable breast lesions.

PMID:
21947587
DOI:
10.1245/s10434-011-1910-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center